Mirxes, a spin-off of Singapore ’s Agency for Science, Technology and Research, will establish a foothold in Hong Kong this year to tap into the vast multi-cancer early-stage screening market in the Greater Bay Area.
Singaporean firm Mirxes enters Hong Kong to tap into growing multi-cancer early-stage screening market in Greater Bay Area
RELATED ARTICLES
Could US-DR Congo ‘minerals-for-security’ deal threaten China’s mining dominance?
US deploys anti-ship missiles in Philippines, holds live-fire drills amid China tensions
Death Toll in Blast in Iran’s Bander Abbas Port Rises to 25 People
